2
Funding Rounds
$158.0m
Money raised
Senti Biosciences is a synthetic biology company.
Industries:
Key people:
- Timothy Lu ***.**@sentibio.com
- Philip Lee ******.***@sentibio.com
- Wilson Wong
3
Funding Rounds
$183.9m
Money raised
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
1
Funding Rounds
$12.8m
Money raised
Kiadis Pharma is a biotechnology company developing stem cell regenerative medicine treatments for blood cancers and blood disorders.
Industries:
Location:
Key people:
2
Funding Rounds
$110.0m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
Location:
Key people:
- Jeffrey Greve *******.*****@ensocell.com
1
Funding Rounds
$71.5m
Money raised
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
3
Funding Rounds
$171.2m
Money raised
Triumvira Immunologics is an adoptive Immunotherapy founded by Jonathan Bramson.
Industries:
Location:
Key people:
2
Funding Rounds
$695.0m
Money raised
ElevateBio is a company founded by Vikas Sinha, David Hallal and Melissa Carpenter.
Industries:
Key people:
- Melissa Carpenter
- David Hallal *******@elevate.bio
- Vikas Sinha ******@elevate.bio
2
Funding Rounds
$43.9m
Money raised
Novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line pre-loaded with peptides
Industries:
Location:
3
Funding Rounds
$192.0m
Money raised
Developer of cell therapy products designed to safely replace patients' diseased blood and immune system with a healthy one.
Industries:
Location:
Key people:
1
Funding Rounds
$172.0m
Money raised
Wugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper, Todd Fehniger, Melissa Berrien-Elliott and John DiPersio.
Industries:
Key people:
- Todd Fehniger
- Matthew Cooper *******@wugen.com
- John DiPersio
1
Funding Rounds
$15.0m
Money raised
Cord Blood Cell Therapy
Industries:
Location:
3
Funding Rounds
$4.0m
Money raised
Luminary Therapeutics is a Minneapolis-based biotechnology company focused on allogeneic therapeutics.
Industries:
Key people:
1
Funding Rounds
$3.5m
Money raised
Cell Therapies is a Seattle, Washington-based clinical-stage biotechnology company focused on the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases.
1
Funding Rounds
$42.0m
Money raised
Catamaran uses NK cells, synthetic biology, and non-viral cell engineering to create novel CAR-NK cell therapies.
2
Funding Rounds
$6.0m
Money raised
mRNA-based technology to develop engineered cell therapies for solid and liquid tumors
Industries:
Location:
Key people:
- Gregory Fiore linkedin
- Matt Angel ****.*****@factorbio.com
- James Pan
1
Funding Rounds
$45.0m
Money raised
Avenge Bio is a cell & Gene Therapies.
Industries:
2
Funding Rounds
$240.0m
Money raised
Aurion Biotech is an ocular Transplant Therapies founded in 2021.
Industries:
Location:
1
Funding Rounds
$87.0m
Money raised
Clade Therapeutics is a stem Cell Therapies founded by Jim Glasheen, Chad Cowan and Leandro Vetcher.
Industries:
Location:
Key people:
1
Funding Rounds
$52.0m
Money raised
Appia Bio is an early-stage biotechnology company based in Los Angeles, California.
Industries:
Location:
1
Funding Rounds
$15.8m
Money raised
Leucid Bio is a cell Therapy.
Industries:
Location:
2
Funding Rounds
$47.0m
Money raised
Anocca is an individualized tcr and antigen cancer treatment founded in 2014.
Location:
1
Funding Rounds
$8.5m
Money raised
Zelluna Immunotherapy is a TCR cancer immunotherapy.